Centene Net Profit Margin 2010-2025 | CNC
Current and historical net profit margin for Centene (CNC) from 2010 to 2025. Net profit margin can be defined as net Income as a portion of total sales revenue. Centene net profit margin for the three months ending March 31, 2025 was .
| Centene Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2025-03-31 |
$169.28B |
$3.45B |
2.04% |
| 2024-12-31 |
$163.07B |
$3.31B |
2.03% |
| 2024-09-30 |
$161.73B |
$3.07B |
1.90% |
| 2024-06-30 |
$157.75B |
$2.82B |
1.79% |
| 2024-03-31 |
$155.52B |
$2.74B |
1.76% |
| 2023-12-31 |
$154.00B |
$2.70B |
1.75% |
| 2023-09-30 |
$150.10B |
$2.44B |
1.63% |
| 2023-06-30 |
$147.92B |
$2.71B |
1.83% |
| 2023-03-31 |
$146.25B |
$1.48B |
1.01% |
| 2022-12-31 |
$144.55B |
$1.20B |
0.83% |
| 2022-09-30 |
$141.55B |
$2.01B |
1.42% |
| 2022-06-30 |
$138.10B |
$1.86B |
1.35% |
| 2022-03-31 |
$133.18B |
$1.50B |
1.12% |
| 2021-12-31 |
$125.98B |
$1.35B |
1.07% |
| 2021-09-30 |
$121.70B |
$0.74B |
0.60% |
| 2021-06-30 |
$118.39B |
$0.72B |
0.61% |
| 2021-03-31 |
$115.07B |
$2.46B |
2.14% |
| 2020-12-31 |
$111.12B |
$1.81B |
1.63% |
| 2020-09-30 |
$101.69B |
$2.03B |
2.00% |
| 2020-06-30 |
$91.58B |
$1.56B |
1.70% |
| 2020-03-31 |
$82.22B |
$0.85B |
1.03% |
| 2019-12-31 |
$74.64B |
$1.32B |
1.77% |
| 2019-09-30 |
$72.34B |
$1.35B |
1.87% |
| 2019-06-30 |
$69.54B |
$1.28B |
1.84% |
| 2019-03-31 |
$65.37B |
$1.08B |
1.66% |
| 2018-12-31 |
$60.12B |
$0.90B |
1.50% |
| 2018-09-30 |
$56.36B |
$0.89B |
1.58% |
| 2018-06-30 |
$52.08B |
$1.08B |
2.06% |
| 2018-03-31 |
$49.85B |
$1.03B |
2.06% |
| 2017-12-31 |
$48.38B |
$0.83B |
1.71% |
| 2017-09-30 |
$47.49B |
$0.86B |
1.81% |
| 2017-06-30 |
$46.44B |
$0.80B |
1.72% |
| 2017-03-31 |
$45.38B |
$0.72B |
1.58% |
| 2016-12-31 |
$40.61B |
$0.56B |
1.38% |
| 2016-09-30 |
$35.00B |
$0.41B |
1.18% |
| 2016-06-30 |
$29.97B |
$0.36B |
1.19% |
| 2016-03-31 |
$24.58B |
$0.28B |
1.12% |
| 2015-12-31 |
$22.76B |
$0.36B |
1.56% |
| 2015-09-30 |
$21.18B |
$0.35B |
1.66% |
| 2015-06-30 |
$19.71B |
$0.34B |
1.72% |
| 2015-03-31 |
$18.23B |
$0.30B |
1.65% |
| 2014-12-31 |
$16.56B |
$0.27B |
1.64% |
| 2014-09-30 |
$14.77B |
$0.22B |
1.47% |
| 2014-06-30 |
$13.21B |
$0.18B |
1.39% |
| 2014-03-31 |
$11.80B |
$0.17B |
1.47% |
| 2013-12-31 |
$10.86B |
$0.16B |
1.51% |
| 2013-09-30 |
$9.77B |
$0.12B |
1.23% |
| 2013-06-30 |
$9.42B |
$0.08B |
0.80% |
| 2013-03-31 |
$8.92B |
$0.00B |
0.01% |
| 2012-12-31 |
$8.11B |
$0.00B |
0.02% |
| 2012-09-30 |
$7.65B |
$0.02B |
0.30% |
| 2012-06-30 |
$6.50B |
$0.05B |
0.74% |
| 2012-03-31 |
$5.71B |
$0.11B |
1.94% |
| 2011-12-31 |
$5.21B |
$0.11B |
2.13% |
| 2011-09-30 |
$5.01B |
$0.11B |
2.11% |
| 2011-06-30 |
$4.83B |
$0.10B |
2.07% |
| 2011-03-31 |
$4.60B |
$0.10B |
2.07% |
| 2010-12-31 |
$4.45B |
$0.10B |
2.14% |
| 2010-09-30 |
$4.36B |
$0.09B |
2.16% |
| 2010-06-30 |
$4.28B |
$0.09B |
2.15% |
| 2010-03-31 |
$4.24B |
$0.09B |
2.10% |
| 2009-12-31 |
$4.10B |
$0.08B |
2.02% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-HMO |
$29.936B |
$163.071B |
|
Centene Corporation is a well-diversified, multi-national healthcare company that primarily provides a set of services to government sponsored healthcare programs. The company serves the under-insured and uninsured individuals through member-focused services. It is also engaged in providing education and outreach programs to inform and assist members in accessing quality, appropriate healthcare services. Through a diversified product portfolio and expanding geographic reach, Centene continues to deliver results by growing premium and service revenues profitably. The company operates in two segments: Managed Care and Specialty Services. Managed Care - This segment provides health plan coverage to individuals through Government subsidized programs, including Medicaid. Specialty Services - This segment consists of its specialty companies offering diversified healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups and other commercial organizations.
|
